Insilico Banks on Growth and Innovation – Capital Increase Completed

10 July 2015

Insilico Biotechnology AG ensures innovation capacity and growth with an increase of capital and with moving into expanded office premises within Stuttgart Engineering Park. read more

Pharmacelsus and Insilico Biotechnology Join Forces to Deliver Combined Solutions in Preclinical Drug Development

10 February 2014

Pharmacelsus, Germany’s market-leading preclinical CRO and Insilico Biotechnology, leading provider of innovative solutions around the simulation of biological processes, combine their expertise in preclinical characterization of drug-candidates. read more

Improving the Welfare of Animals: Researchers Develop Computer-Aided Models to Replace Animal Testing

04 October 2013

Every year, October 4 is all about the protection of animals. On World Animal Day, animal welfare organisations around the globe advocate the respectful treatment and welfare of animals. One of the central demands of the animal activists is to abolish animal testing and to use alternative testing methods instead. In this context, the European Union has taken a huge step forward at the beginning of this year: On March 11 a full ban on the marketing of cosmetics and hygiene products tested on animals entered into force in the EU. read more

Insilico Presents New Software Solution for the Automated Analysis of Bioprocesses

05 June 2013

Insilico Biotechnology AG has developed an innovative enterprise software, Insilico Inspector™, which is unique in that it can carry out a metabolic analysis of bioprocesses automatically and directly from process data for the very first time. The software can be used not only for the time-resolved quantitative analysis but also for the graphically supported comparison of the performance of fermentation processes, strains and cell lines. read more

Technology Platform for Virtual Organs

14 March 2013

Insilico Biotechnology AG has successfully concluded another step in the further development of its existing technology platform for simulating biochemical processes in living cells. A model of the liver including blood flow is now available. The platform offers benefits in particular to customers from the pharmaceutical, chemical and cosmetics industries, who can use this technology to perform computer-based toxicity tests. read more